Follow
About Adam
Adam Johnson is the founder and author of BullseyeBrief.com, a weekly investment letter that explores American Ingenuity through actionable stock picks. He also runs the American Ingenuity portfolio at Kensington Investment Counsel. Previously he anchored several daily programs at Bloomberg Television, interviewing CEOs, heads of state, and prominent investors. During his three-decade career on Wall Street, he has traded stocks, options, and oil for ING Asset Management, Louis Dreyfus, and Merrill Lynch. He graduated from Princeton with a degree in economics. He resides in New York City.
Adam's Articles
CVS Health Corp. (CVS) is a healthcare leader and the sixth-largest US company by sales. It’s trading at a record low valuation, despite solid growth and a strong outlook, making it a buy, argues Adam Johnson, editor of Bullseye Brief.
Adam Johnson
CONSUMER
Walt Disney Company (DIS) turns 100 this year and will make more money than ever before, potentially posting a third consecutive year of double-digit growth, notes Adam Johnson, growth stock expert and editor of Bullseye Brief.
Adam Johnson
CONSUMER
Tickers: DIS
Investors plowed $508B into money market funds during Q1, the most since Covid. But when everyone runs for the exit, choose the best seats in the house and make yourself comfortable. Alexandria Real Estate Equities (ARE) is one of them, notes Adam Johnson, editor of Bullseye Brief.
Adam Johnson
REITS
Tickers: ARE
I have owned EOG Resources (EOG) many times over many years. It’s the best managed oil exploration company — with the best technology, the best balance sheet and best drill sites in the business, asserts Adam Johnson, editor of Bullseye Brief.
Adam Johnson
ENERGY
Tickers: EOG
Adam's Videos
How we move is changing fast and it's not about building a faster Tesla. 30-ft drones transport US Air Force personnel across sprawling bases. Fuel cells power construction equipment, lifting thousands of pounds. Electric delivery vans make UPS greener and our air cleaner. Several pioneering companies are propelling the world forward at record speed. The question is which ones to buy today? Join Adam Johnson to discover how the future of mobility is now.
Adam Johnson
TECHNOLOGY
33:37
SpaceX made history with the launch into orbit of the first manned space capsule by a private company. While we may not be vacationing in Mars any time soon, we are living in a world where technology is evolving faster than ever. In this panel discussion, get up to speed on the latest trends in the industry, explore breakthrough technologies, and hear about the most innovative disruptors reshaping the future.
Adam Johnson
TECHNOLOGY
53:04
Tune in to this 30-minute session to discuss several Med-Tech hybrid companies as case studies, explaining how they're redefining health and moving the world forward. Adam Johnson is long on all of them, and see's significant upside. "Health Care's Holy Grail" is his biggest investment theme for 2021, thanks to the convergence of wearables, AI, 5G, and telemedicine, and he's excited to share with you what he has learned!
Adam Johnson
BIOTECH
32:37
Biotechnology offers significant upside if you know where to look. Adam Johnson, founder of BullseyeBrief.com, shares his three favorite biotech stocks under $3, why he's long and what he expects. These are some of the best examples of American Ingenuity!
Adam Johnson
BIOTECH
37:47
